Outcomes for patients (Pts) with low-/int-1-risk myelodysplastic syndromes (MDS) with del5q aged < 65 years treated with lenalidomide (LEN) in MDS-003 and MDS-004: A retrospective combined analysis Meeting Abstract


Authors: Fenaux, P.; Giagounidis, A.; List, A. F.; Nimer, S. D.; Hellstrom-Lindberg, E.; Powell, B. L.; Yu, X. J.; Skikne, B.; Shammo, J. M.; del Canizo, C.
Abstract Title: Outcomes for patients (Pts) with low-/int-1-risk myelodysplastic syndromes (MDS) with del5q aged < 65 years treated with lenalidomide (LEN) in MDS-003 and MDS-004: A retrospective combined analysis
Meeting Title: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Journal Title: Blood
Volume: 118
Issue: 21
Meeting Dates: 2011 Dec 10-13
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2011-11-01
Start Page: 750
End Page: 751
Language: English
ACCESSION: WOS:000299597102318
PROVIDER: wos
DOI: 10.1182/blood.V118.21.1723.1723
Notes: --- - Meeting Abstract: 1723 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen D Nimer
    347 Nimer